LONDON (Alliance News) - LiDCO Group PLC on Tuesday said it appointed Tim Hall to the board as chief financial officer and company secretary with effect from March 11.
Hall was CFO of Oxford Gene Technology from 2012 until shortly after its recent acquisition by Sysmex Corp, the hemodynamic monitoring company said.
Prior to this, he was finance director at AIM-listed Lombard Medical Technologies PLC for six years and held senior finance roles in UCB SA, Celltech Group PLC and Medeva PLC.
Hall succeeds Jill McGregor who will leave the company on March 22.
LiDCO shares were trading up 1.9% at 3.47 pence each.